Evidence map›Paper›PMID 31309582›Full record

ArticleJournal of fish diseases2019

Further evaluation of the efficacy of emamectin benzoate for treating Pseudocapillaria tomentosa (Dujardin 1843) in zebrafish Danio rerio (Hamilton 1822).

Michael L Kent, Virginia Watral, Christopher A Gaulke, Thomas J Sharpton

Open access · greenAbstract read
In one paragraph

Article in Journal of fish diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. bioRxiv : the preprint server for biology · 2025
    Article
  3. Current research in parasitology & vector-borne diseases · 2025
    Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Michael L KentDepartment of Microbiology, Oregon State University, Corvallis, Oregon.ORCID https://orcid.org/0000-0001-7968-5142
Virginia WatralDepartment of Microbiology, Oregon State University, Corvallis, Oregon.
Christopher A GaulkeDepartment of Microbiology, Oregon State University, Corvallis, Oregon.
Thomas J SharptonDepartment of Microbiology, Oregon State University, Corvallis, Oregon.
Oregon State University · US

Funding

Reducing Susceptibility to Environmental Stress Throughout the Life SpanP30ES000210 · NIEHS · OREGON STATE UNIVERSITY · PI BECKMAN, JOSEPH S · 1985 to 2015
$21.4M
Control of Diseases in Zebrafish Research FacilitiesR24OD010998 · OD · OREGON STATE UNIVERSITY · PI KENT, MICHAEL LAWRENCE · 2012 to 2021
$3.0M
Interactions between Gut Microbiome Natural Products and Intestinal HelminthsR21AI135641 · NIAID · OREGON STATE UNIVERSITY · PI KENT, MICHAEL LAWRENCE, SHARPTON, THOMAS JEFFERSON · 2018 to 2019
$404k
NIAID NIH HHS R21 AI135641NIEHS NIH HHS P30 ES000210NIH HHS R24 OD010998NIH ORIP R24OD010998Oregon State University
6 · The paper itself

Abstract

Pseudocapillaria tomentosa is a pathogenic nematode parasite, causing emaciation and severe inflammatory lesions in the intestines in zebrafish Danio rerio (Hamilton 1822). Emamectin benzoate is commercially available analogue of ivermectin used for treating salmon for sea lice, under the brand name SLICE

Indexed as

ZebrafishAnimalsAntinematodal AgentsDose-Response Relationship, DrugEnoplidaEnoplida InfectionsFemaleFish DiseasesIvermectinMaleAntinematodal Agentsemamectin benzoateIvermectinemamectin benzoatePseudocapillaria tomentosazebrafish Danio rerio

Identifiers

PMID31309582
PMCPMC6744302
OpenAlexW2962175730

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.